| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/21/1985 | US4518586 GRF Analogs III |
| 05/21/1985 | US4518584 Human recombinant interleukin-2 muteins |
| 05/21/1985 | US4518528 α Amino fluoro ketones |
| 05/21/1985 | US4518525 Complexing with cmc |
| 05/21/1985 | CA1187641A1 High impact compositions containing polycyano norbornenes, halogenated polyolefin and abs resin |
| 05/21/1985 | CA1187486A1 Allantoin collagen amino acid compositions |
| 05/21/1985 | CA1187432A1 Microorganism and its use for the preparation of glutathione |
| 05/21/1985 | CA1187412A1 Method for stabilizing a tumor necrosis factor and a stable aqueous solution or powder containing the same |
| 05/21/1985 | CA1187411A1 Process for the preparation of plasminogen and plasminogen thus prepared |
| 05/21/1985 | CA1187410A1 Pasteurized therapeutically active protein compositions |
| 05/15/1985 | EP0141783A2 Immune response to tumours and viruses induced by anti-idiotype antibodies |
| 05/15/1985 | EP0141779A1 T-cell growth factor |
| 05/15/1985 | EP0141711A2 Conjugates prepared by fixing a ligand to an insoluble support, their preparation and their biological applications |
| 05/15/1985 | EP0141483A1 Metorphamide - a novel morphine-like peptide |
| 05/15/1985 | EP0141326A2 Protein PP20, process for its recovery and its use |
| 05/15/1985 | EP0141079A2 Monoclonal antibodies specific for membrane-associated antigens |
| 05/15/1985 | EP0140998A1 Ophthalmic preparations |
| 05/14/1985 | US4517303 Specific binding assays utilizing analyte-cytolysin conjugates |
| 05/14/1985 | US4517294 Human antithrombin III |
| 05/14/1985 | US4517293 High yield process for in vitro production of serum-free and mitogen-free interleukin-2 using a roller bottle culture system |
| 05/14/1985 | US4517181 Hypothalamic growth hormones releasing factor |
| 05/14/1985 | US4517180 Peptides, process for preparing the same and psychodepressant compositions containing the same |
| 05/14/1985 | US4517119 Synthesis of thymosin α1 |
| 05/14/1985 | US4516276 Bone substitute and a method of production thereof |
| 05/14/1985 | CA1187087A1 Derivatives of cis, endo-2-azabicyclo-[3.3.0]- octane-3-carboxylic acid, a process for their preparation, agents containing these compounds and their use |
| 05/14/1985 | CA1187076A1 Protein pp.sub.9, process for its enrichment and its isolation and its use |
| 05/14/1985 | CA1187074A1 Antithrombin-heparin complex and method for its production |
| 05/14/1985 | CA1187013A1 PROCESS FOR RECOVERING HUMAN IFN-.beta. FROM A TRANSFORMED MICROORGANISM |
| 05/14/1985 | CA1186995A1 Fibrinogen formulation, a process for its preparation and its use |
| 05/14/1985 | CA1186994A1 Therapeutic method and method for making compositions for use therein |
| 05/14/1985 | CA1186993A1 Protein (pp in16 xx), a process for concentrating and isolating it, and its use |
| 05/09/1985 | WO1985001961A1 Production of factor viii and related products |
| 05/09/1985 | WO1985001959A1 Production of heterodimeric human fertlity hormones |
| 05/09/1985 | WO1985001958A1 Production of heterodimeric human fertility hormones |
| 05/09/1985 | WO1985001941A1 Method for the purification and isolation of blood clotting proteins using conformation specific antibodies |
| 05/08/1985 | EP0140731A2 Natriuretic factors |
| 05/08/1985 | EP0140640A2 Blood substitute |
| 05/08/1985 | EP0140627A2 Production of livestock or products derived therefrom |
| 05/08/1985 | EP0140498A1 Caries-preventive composition |
| 05/08/1985 | EP0140308A2 Regulation of gene expression by employing translational inhibition utilizing mRNA interfering complementary RNA |
| 05/08/1985 | EP0140255A2 Sustained-release injections |
| 05/08/1985 | EP0140134A2 Process for the preparation of a biologically active extract |
| 05/08/1985 | EP0140127A1 Process for the preparation of immune interferon |
| 05/08/1985 | EP0140109A2 Allograft of reduced immunogenicity and method and reagent for making same |
| 05/08/1985 | EP0140084A1 Process for the preparation of insulin derivatives with a C-terminally elongated B-chain, basically modified insulin derivatives, compositions containing them and their use |
| 05/08/1985 | EP0139975A1 Method for the pasteurization of human plasma |
| 05/08/1985 | EP0139878A2 Production of immune interferon and its mRNA |
| 05/07/1985 | US4515895 Diagnosis and treatment of immunoregulatory disorders |
| 05/07/1985 | US4515894 Hybrid cell line for producing monoclonal antibody to human T cells |
| 05/07/1985 | US4515893 Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells |
| 05/07/1985 | US4515891 Process for the production of disaccharide-tripeptide and disaccharide-tetrapeptide |
| 05/07/1985 | US4515809 Anticholesterol |
| 05/07/1985 | US4515776 Removal of aggregates |
| 05/07/1985 | US4515715 Immunostimulants, immunoadjuvants |
| 05/07/1985 | US4515637 Collagen-thrombin compositions |
| 05/07/1985 | CA1186683A1 Nonapeptide, a process for its preparation, an agent containing it and its use |
| 05/07/1985 | CA1186629A1 Biologically active substance, process for preparing the substance and immunoactive composition |
| 05/07/1985 | CA1186627A1 Process for making novel blood clotting enzyme compositions |
| 05/07/1985 | CA1186626A1 Process for the purification of the blood clotting factors ii, vii, ix and/or x and preparation prepared by this process |
| 05/02/1985 | EP0139555A1 Synthetic peptide, process for its preparation, and drugs thereof |
| 05/02/1985 | EP0139383A1 Method for expressing foreign genes in schizosaccharomyces pombe and the use in therapeutic formulations of the products, DNA constructs and transformant strains of schizosaccharomyces pombe usable in such method and their preparation |
| 05/02/1985 | EP0139286A2 Prolonged sustained-release preparations |
| 05/02/1985 | EP0139216A2 Adult T cell leukemia virus antigen peptide |
| 05/02/1985 | EP0139201A1 Diagnostic method and kit |
| 05/02/1985 | EP0139076A2 Human-parathyroid hormone (human-PTH) producing hybrid vector |
| 05/02/1985 | EP0139024A1 Injectable compositions of BBM-928A |
| 04/30/1985 | US4514391 Hypotensive agents; analgesics |
| 04/30/1985 | US4514388 Proenzymes of trypsinogen or chymotrypsinogen |
| 04/30/1985 | US4514387 Chemokinesins and chemotaxins of leukocytes and inflamed tissues |
| 04/30/1985 | US4514331 Peptide hormones with calcitonin-like activity |
| 04/30/1985 | US4514330 Carbon-7-substituted atinomycin D analogue |
| 04/30/1985 | CA1186303A1 Polypeptide compositions |
| 04/30/1985 | CA1186302A1 Lrf antagonists |
| 04/30/1985 | CA1186255A1 Immobilized superoxide dismutase and its production |
| 04/30/1985 | CA1186223A1 Isolation of principal outer membrane protein and antigen of chlamydia trachomatis |
| 04/25/1985 | WO1985001730A1 Fused 7-membered ring compounds and process for their preparation |
| 04/25/1985 | WO1985001659A1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/25/1985 | WO1985001658A1 Human calcitonin-gene-related-peptide |
| 04/25/1985 | WO1985001653A1 Process for the preparation of medicinal cosmetic compositions |
| 04/24/1985 | EP0138704A2 Hepatitis A-subunit antigen |
| 04/24/1985 | EP0138632A2 Complexes containing oligosaccharides, their preparation and their biological and biochemical application |
| 04/24/1985 | EP0138616A2 Nona- and dodecapeptides for augmenting natural killer cell activity, processes for making them and pharmaceutical compositions comprising them |
| 04/24/1985 | EP0138604A2 Arginine vasopressin antagonists |
| 04/24/1985 | EP0138572A2 Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same |
| 04/24/1985 | EP0138544A2 A method for overcoming trypsin inhibition |
| 04/24/1985 | EP0138416A2 Growth hormone release factor analogs |
| 04/24/1985 | EP0138216A2 Sustained-release IFN preparation for parenteral administration |
| 04/24/1985 | EP0138133A1 cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity and/or mast cell growth factor activity |
| 04/24/1985 | EP0138111A1 Superoxide dismutase cloning and expression in microorganisms |
| 04/24/1985 | EP0138087A1 Immune interferon and method for its purification |
| 04/24/1985 | EP0137904A2 Biologically active peptides structurally related to regions within growth hormones |
| 04/24/1985 | EP0137869A2 Derived nisin producing microorganisms, method of production and use and products obtained thereby |
| 04/23/1985 | US4513083 Staphylocidin from rothia dentocariosa |
| 04/23/1985 | US4512988 Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines |
| 04/23/1985 | US4512980 Immunologically effective |
| 04/23/1985 | US4512979 Dipeptides containing thialysine and related amino acids as antihypertensives |
| 04/23/1985 | US4512977 Selenium cystine, selenium methionine, salts of carboxylic acids, inorganic selenates or selenites |
| 04/23/1985 | US4512974 Administering leukocyte endogenous mediator |
| 04/23/1985 | US4512973 Method for overcoming trypsin inhibition |
| 04/23/1985 | US4512971 Mitogens of leukocytes and inflamed tissues |